Insights

Growing Market Presence XenoTech is part of BioIVT, which has recently expanded its portfolio through acquisitions and partnerships, including the acquisition of Cytesbiotech and collaborations with prominent organizations like IDBS and Emily Whitehead Foundation, demonstrating a strong growth trajectory and increasing influence in the research services industry.

Strategic Focus on ADME and DDI The company's specialization in ADME (Absorption, Distribution, Metabolism, and Excretion) and drug-drug interaction studies positions them as a critical partner for pharmaceutical companies seeking early safety and efficacy data, presenting opportunities to offer advanced bioanalytical tools and personalized research solutions.

Innovative Product Launches BioIVT recently launched LEUKOMAX XL, providing researchers with larger quantities of cells from a single donor, indicating a commitment to developing novel, high-quality research products that could attract additional customer interest and expand sales in cell-based research markets.

Active Engagement at Industry Events Participation in key industry conferences such as Cell & Gene Meeting and Precision Med TRI-CON highlights BioIVT’s proactive approach to market visibility and relationship building, offering sales teams multiple touchpoints to connect with decision-makers in cutting-edge research sectors.

Rich Industry Network With a broad client base that includes top pharmaceutical companies, biotechs, research institutes, and universities, there are significant opportunities to cross-sell services, collaborate on customized research projects, and tailor solutions to meet the evolving needs of innovative drug development programs.

Similar companies to XenoTech, LLC

XenoTech, LLC Tech Stack

XenoTech, LLC uses 8 technology products and services including Microsoft 365, Paychex, Element UI, and more. Explore XenoTech, LLC's tech stack below.

  • Microsoft 365
    Email
  • Paychex
    Human Resource Management System
  • Element UI
    Javascript Frameworks
  • Microsoft
    Miscellaneous
  • Qualtrics
    Online Form Builders
  • Cloudflare Bot Management
    Security
  • ZURB Foundation
    UI Frameworks
  • OpenResty
    Web Servers

Media & News

XenoTech, LLC's Email Address Formats

XenoTech, LLC uses at least 3 format(s):
XenoTech, LLC Email FormatsExamplePercentage
FLast@xenotechllc.comJDoe@xenotechllc.com
91%
First.Last@xenotechllc.comJohn.Doe@xenotechllc.com
9%
FLast@xenotech.comJDoe@xenotech.com
78%
First-Last@xenotech.comJohn-Doe@xenotech.com
14%
L.First@xenotech.comD.John@xenotech.com
5%
LastFir@xenotech.comDoeJoh@xenotech.com
1%
Last.First@xenotech.comDoe.John@xenotech.com
2%
FLast@bioivt.comJDoe@bioivt.com
99%
First_Last@bioivt.comJohn_Doe@bioivt.com
1%

Frequently Asked Questions

What is XenoTech, LLC's phone number?

Minus sign iconPlus sign icon
You can contact XenoTech, LLC's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is XenoTech, LLC's official website and social media links?

Minus sign iconPlus sign icon
XenoTech, LLC's official website is bioivt.com and has social profiles on LinkedIn.

What is XenoTech, LLC's NAICS code?

Minus sign iconPlus sign icon
XenoTech, LLC's NAICS code is 5417 - Scientific Research and Development Services.

How many employees does XenoTech, LLC have currently?

Minus sign iconPlus sign icon
As of December 2025, XenoTech, LLC has approximately 95 employees across 3 continents, including North AmericaAsiaEurope. Key team members include Chief Information Officer: B. P.Chief Finance Officer: H. M.Chief Pitmaster: J. M.. Explore XenoTech, LLC's employee directory with LeadIQ.

What industry does XenoTech, LLC belong to?

Minus sign iconPlus sign icon
XenoTech, LLC operates in the Research Services industry.

What technology does XenoTech, LLC use?

Minus sign iconPlus sign icon
XenoTech, LLC's tech stack includes Microsoft 365PaychexElement UIMicrosoftQualtricsCloudflare Bot ManagementZURB FoundationOpenResty.

What is XenoTech, LLC's email format?

Minus sign iconPlus sign icon
XenoTech, LLC's email format typically follows the pattern of FLast@xenotechllc.com. Find more XenoTech, LLC email formats with LeadIQ.

When was XenoTech, LLC founded?

Minus sign iconPlus sign icon
XenoTech, LLC was founded in 1994.

XenoTech, LLC

Research ServicesKansas, United States51-200 Employees

XenoTech is a contract research organization (CRO) specializing in nonclinical drug metabolism & drug-drug interaction (DDI) studies that is part of the BioIVT family. 

Over 25 years, we have grown to serve 98% of the top pharmas plus medium, small and virtual pharma, biotechs, research institutions & universities, and more by assisting them with pharmacokinetics-related safety studies for the drug candidates they are developing, usually before clinical trials. Our leadership and expertise is trusted by industry professionals and academics alike to provide not only superior services and products, but also industry-leading research and new techniques. 

There’s a lot of nuance to understanding pharmacokinetic properties of drug candidates. How they enter/exit specific cells, how long they stay, how they get metabolized by enzymes and what metabolites result—all these properties make up the research area called ADME (Absorption, Distribution, Metabolism and Excretion). ADME represents a key area of preclinical investigation to determine whether a drug is going to be dangerous to someone and to make sure it’s in the correct dose and form to produce the therapeutic effect it’s meant to. In vitro and in vivo studies planned with a consultative approach and tailored study design are key to achieving useful, reliable ADME data.

DDIs are a preventable cause of adverse drug reactions which kill or hurt 350,000 hospitalized patients per year. DDI potential can be evaluated using in vitro data and is encouraged by regulatory authorities to be appropriately investigated early in a drug’s development. Our clients come to us because we are global experts in predicting potential DDI issues in the lab before they could happen in a clinical trial volunteer. Doing these studies earlier and with a trusted expert not only instills confidence in your data, but saves money and reduces your risk of late-stage failure.

Learn more about who we are & how we help at https://bioivt.com/

Section iconCompany Overview

Phone number
Website
bioivt.com
NAICS Code
5417 - Scientific Research and Development Services
Founded
1994
Employees
51-200

Section iconFunding & Financials

  • $50M$100M

    XenoTech, LLC's revenue is estimated to be in the range of $50M$100M

Section iconFunding & Financials

  • $50M$100M

    XenoTech, LLC's revenue is estimated to be in the range of $50M$100M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.